Medical devices, healthcare technology and the business of care
PMA approval · P100045

CARDIOMEMS HF PRESSURE MEASUREMENT SYSTEM

ABBOTT MEDICAL · Decision date May 28, 2014

MEDTECHLEDGER EXPLANATIONP100045

What did the FDA approve?

The May 28, 2014 approval covers the CardioMEMS HF System, including the CM2000 implantable pulmonary artery sensor/monitor and transvenous catheter delivery system, the CM1000 and CM1010 patient electronics systems, and the CM3000 hospital electronics system. The stated indication is wireless measurement and monitoring of pulmonary artery pressure and heart rate in NYHA Class III heart failure patients hospitalized for heart failure in the previous year.

The approval statement says hemodynamic data are used by physicians for heart failure management with the goal of reducing heart failure hospitalizations. This reported purpose is distinct from independent proof of safety or clinical effectiveness. The statement does not include supplement type or reason, so no relationship to a prior PMA is established.

FDA approval order statement

APPROVAL FOR THE CARDIOMEMS HF SYSTEM, WHICH INCLUDES THE CM2000 IMPLANTABLE PA SENSOR/MONITOR AND TRANSVENOUS CATHETER DELIVERY SYSTEM, THE CM1000 PATIENT ELECTRONICS SYSTEM (GSM), THECM1010 PATIENT ELECTRONICS SYSTEM (GSM), AND CM3000 HOSPITAL ELECTRONICS SYSTEM. THIS DEVICE IS INDICATED FOR WIRELESSLY MEASURING AND MONITORING PULMONARY ARTERY (PA) PRESSURE AND HEART RATE IN NEW YORK HEART ASSOCIATION (NYHA) CLASS III HEART FAILURE PATIENTS WHO HAVE BEEN HOSPITALIZED FOR HEART FAILURE IN THE PREVIOUS YEAR. THE HEMODYNAMIC DATA ARE USED BY PHYSICIANS FOR HEART FAILURE MANAGEMENT AND WITH THE GOAL OF REDUCING HEART FAILURE HOSPITALIZATIONS.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
May 28, 2014

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P100045
Regulatory pathway
Premarket approval application
Product code
MOM
Decision code
APPR
Decision date
May 28, 2014
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, hemodynamic, implantable.

Product code
MOM
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P100045 received

    Application receipt date recorded by FDA.

  2. P100045 · FDA decision

    APPR

  3. P100045/S092 · Related supplement

    CardioMEMS PA Sensor and Delivery System (CM2000); CardioMEMS HF System

  4. P100045/S091 · Related supplement

    CardioMEMS HF System; Merlin.net PCN HF Portal (Model MN6000); CardioMEMS Backend Web Application (Model CM4000); HF Clo

  5. P100045/S093 · Related supplement

    CardioMEMS PA Sensor and Delivery System

Timeline entries are records held by MedtechLedger for P100045. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100045

Explore the linked device profile

Other records with product code MOM

Product / regulatory recordCompanyPathwayDecision dateSource
Endotronix, Inc.PMA supplementOct 29, 2026FDA
Endotronix, Inc.PMA supplementOct 20, 2026FDA
Endotronix, Inc.PMA supplementOct 16, 2026FDA
Endotronix, Inc.PMA supplementOct 14, 2026FDA
Endotronix, Inc.PMA supplementSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
387 Nerem St. NW, Suite #500, Atlanta, GA, 30313

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records